Clinical Trial: Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit

U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07925502) titled 'Post Market Clinical Follow-Up Registry Study of the aXess Hemodialysis Conduit' on Nov. 03.

Brief Summary: A prospective, single arm, non-randomized Post Market Clinical Follow-up (PMCF) registry study to evaluate the safety and performance of the aXess Hemodialysis Conduit, called aXess4All. Intended for Patients older than 18 years of age with end-stage renal disease who require a vascular access for hemodialysis, compliant with the Instructions for Use who consented in study participation.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: End Stage Renal Failure, Hemodialysis

Intervention: DEVICE: Xeltis a...